PFAS restrictions and medicines: what is the EU proposing, and how it might affect lung cancer treatment
The EU is consulting on new restrictions on PFAS chemicals, also known as “forever chemicals.” Lung Cancer Europe explains what the proposed regulation involves, why it matters for medicine supply, and how we are engaging with the process.
RET fusion-positive lung cancer: a field transformed by science
RET fusions drive around 1 to 2% of all lung cancers. For years, treatment options were limited. That has changed. New data from ASCO 2026 show that targeted therapies now span multiple stages of RET fusion-positive lung cancer, with next-generation options already in development. Lung Cancer Europe explains the science, the treatments, and what to ask your oncologist.
Lung Cancer Europe at the World Cancer Series Europe 2026
Lung Cancer Europe President Debra Montague joined a panel on lung cancer control at the World Cancer Series Europe 2026 in Brussels on 8 June.
Lung cancer in women: what ASCO 2026 and a new Nature review tell us
Last week, two things converged. The world's largest oncology conference brought thousands of researchers to Chicago. And Nature published an article declaring lung cancer in women a distinct disease. The timing was not coincidental.
Blood test predicts lung cancer five years early: what the new Cell research means
Scientists at the Francis Crick Institute and UCL have identified 14 proteins in blood that can predict lung cancer more than five years before diagnosis. The research, published in Cell on 4 June 2026, also points toward a prevention strategy. Here is what it found and why it matters for people affected by lung cancer across Europe.
How the EU’s Next Long-Term Budget Will Affect People Living with Lung Cancer
Lung Cancer Europe President Debra Montague is among more than 490 healthcare experts, researchers, academics, and patient advocates calling for a dedicated, ring-fenced health budget in the EU’s next long-term budget. Here is what the MFF 2028-2034 negotiations mean for people living with lung cancer across Europe.
World No Tobacco Day 2026: protecting the next generation and supporting people who smoke
Tobacco is the single largest preventable cause of lung cancer in Europe. But lung cancer can affect anyone, including people who have never smoked. On World No Tobacco Day 2026, Lung Cancer Europe calls for stronger EU tobacco regulation to protect young people from targeted marketing, and compassionate support for people who want to quit.
